Aquatic Capital Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-23,173
Closed -$368K – 1414
2026
Q1
$368K Buy
23,173
+4,936
+27% +$107K 0.01% 845
2025
Q4
$479K Sell
18,237
-24,536
-57% -$636K 0.01% 751
2025
Q3
$967K Sell
42,773
-26,007
-38% -$536K 0.02% 683
2025
Q2
$1.37M Buy
68,780
+47,975
+231% +$935K 0.03% 569
2025
Q1
$352K Buy
20,805
+7,936
+62% +$135K 0.01% 825
2024
Q4
$238K Buy
12,869
+7,869
+157% +$154K 0.01% 889
2024
Q3
$109K Buy
+5,000
New +$112K ﹤0.01% 915
2024
Q2
– Sell
-3,800
Closed -$82.5K – 1351
2024
Q1
$82.5K Buy
+3,800
New +$94.4K ﹤0.01% 958
2023
Q4
– Sell
-2,700
Closed -$72K – 1427
2023
Q3
$72K Buy
+2,700
New +$92.2K ﹤0.01% 894
2023
Q1
– Sell
-11,800
Closed -$352K – 1415
2022
Q4
$352K Buy
+11,800
New +$422K 0.03% 590

Other funds holding FLGT

Aquatic Capital Management's FLGT Position: Q2 2026 in Review

Aquatic Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 23,173 shares — an estimated $368K sold.

Aquatic Capital Management first reported a position in FLGT in Q4 2022 and held it in 10 quarters. The position peaked at $1.37M in Q2 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Aquatic Capital Management reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 23,173 Fulgent Genetics shares in Q2 2026, an estimated $368K.
  • Aquatic Capital Management first reported a position in Fulgent Genetics in Q4 2022 and held it in 10 quarters.
  • Aquatic Capital Management's Fulgent Genetics position peaked at $1.37M in Q2 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.